Enzyvant Appoints Johanna Rossell as Chief Commercial Officer Learn More

Our Product

The product information below is intended for U.S. residents only.

You are encouraged to report side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088 (1-800-332-1088).
You may also report side effects to Enzyvant at 1-833-369-9868, or [email protected].

Patient Support

Enzyvant CONNECT is a program that provides patients and caregivers personalized support throughout the treatment journey, including:

  • Work with insurers to help families mobilize insurance coverage for congenital athymia treatment
  • Help families understand what, if any, out-of-pocket costs they can expect
  • Connect families with experienced people who can help them through the entire process
  • Provide tools to guide families through each step along the treatment journey

To learn more and enroll visit EnzyvantConnect.com
or call us at 844-ENZCNCT (844-369-2628)

Visit Enzyvant Connect

Contact us for more information